OrphAI Therapeutics Announces Oral Presentation and Posters at the 22nd Annual NEALS Conference
October 02, 2023 11:38 ET
|
OrphAI Therapeutics Inc.
GUILFORD, Conn., Oct. 02, 2023 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today data...